Docket Number:13A-990115
Inventor:Che-Kun James Shen,Ruei-Lin Chen, Yu-Chi Chou
IP Status:TW I432730、US pending
Abstract:
The human alpha-like and beta-like globin gene clusters each extends over 50 kb on chromosomes 16 and 11, respectively. Expression of the genes within both clusters in erythroid cells are under temporal control during development, with reciprocal silencing of the embryonic/fetal globin genes and induction of the fetal/adult globin genes in a gene-order manner (hemoglobin switch). A number of previous studies have shown that the erythroid tissue- and developmental stage-specific expression of the mammalian globin gene clusters including those of the humans are regulated by a variety of different protein-DNA and protein-protein complexes formed at different DNA sequence motifs within the globin gene promoters and their upstream regulatory elements, i.e. the beta-LCR and alpha-HS-40.
Identification and detailed analysis of the transcription repressors of the embryonic/fetal globin genes would allow the design of appropriate therapeutic approached to re-turn on these genes, thus substitute for the functioning of the defective/silenced/deleted adult alpha or beta globin gene in sickle cell anemia and severe thalassemia.Using a variety of molecular, cellular, and transgenic mice technologies, we have acquired novel evidence that the protein RREB1 is a repressor responsible for developmental silencing of the human embryonic and globin gene expression. Thus, we suggest/ propose that RREB1 can be used as the target for designing of new therapeutic approaches and development of new drugs to return-on the expression of human and globin gene expression in fetal/ adult erythroid cells of patients with thalassemias or sickle cell anemia.
Fields of Application:
Durg screenign
Advantages when compared to the existing technologies:
An easy and cheap system
Contact Person:Sue-Ming Chang / 886-2-2787-2600 / name4517@gate.sinica.edu.tw
